Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
The Association for Accessible Medicines' latest policy framework aims to boost the manufacture of critical drugs in the USA.
Pfizer is supporting homelearners amid the COVID-19 pandemic.
From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.
Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?
How is the business of making medicine changing in light of the COVID-19 pandemic?
When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.
It’s time to address the bottlenecks that lie in quality assurance review and release – and digital systems can help.
Why finding new talent is crucial to the success of the cell and gene therapy industry.
Experts from the UK discuss how the country is tackling the CGT skills gap.
Will West and Schott’s collaboration pave the way for more vendor-to-vendor partnerships?
What measures can companies take to ensure the safety of their employees amid the COVID-19 outbreak?
Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer, and Chief Medical Officer of Immutep, France.
How fakers are taking advantage of the pandemic.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.